In a remarkable feat of advanced surgical care, the hospital in Kolkata has successfully performed a 10-hour-long, high-risk surgery on a 60-year-old patient diagnosed with severely advanced ovarian ...

Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic ...

An expert discusses how different adverse event profiles of antibody-drug conjugates (ADCs) influence treatment decisions by requiring careful patient selection based on comorbidities like prior lung ...

An expert discusses how clinicians and institutions can streamline biomarker-driven therapy decisions by establishing rapid turnaround times for biopsies and pathology results, maintaining in-house ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves - insights ...

When Gibson died on Monday, at age 49, those closest to the poet consoled mourning fans by sharing some of Gibson’s last ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights ...